Skip to main content
OpenTrials
Completed

NCT Number: NCT07129122

A Novel Technique for Percutaneous Mitral Paravalvular Leak Closure: LBBAP Lead Assisted Ventricular Septal Way

The investigators will perform closure the mitral paravalvular leak in patient with mechanical aortic and mitral valve.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi

Bursa, Turkey (Türkiye)

About this study

The mitral mitral paravalvular leak closure access are left atrial and transapical in patient with mechanical aortic and mitral valve.

In this case the investigators will use interventricular septal access.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Had mitral paravalvüler leak Had mitral and aortic mechanical valve

Exclusion criteria

  • Not suitable for left subclavian access Active infection

Treatment and study plan

Transventricular access

Other

Transventricular access will perform with LBBAP lead from left subclavian way.

Primary outcomes

  1. mitral paravalvüler leak closure sucsess

    Time frame: 2 day

Other outcomes

  1. mitral paravalvüler leak closure sucsess without complication

    Time frame: 2 day

Sponsors and collaborators

Lead sponsor

Bursa Postgraduate Hospital

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Aug 19, 2025
Registry last updated
Aug 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.